Supplementing copper at the upper level of the adult dietary recommended intake induces detectable but transient changes in healthy adults

Journal of Nutrition

Volumn 135, Issue 10, 2005, Pages 2367-2371

  Araya, Magdalena ^a   Olivares, Manuel ^a   Pizarro, Fernando ^a   Méndez, Marco A ^a   González, Mauricio ^a   Uauy, Ricardo ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Copper; Glutathione; Humans; Liver aminotransferases; Super oxide dismutase

Indexed keywords

AMINOTRANSFERASE; CERULOPLASMIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; DRINKING WATER; GLUTATHIONE; HOMOCYSTEINE; UNITHIOL;

ADULT; ARTICLE; COPPER METABOLISM; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIVER DYSFUNCTION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; RISK ASSESSMENT;

EID: 26444481575     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.10.2367     Document Type: Article

References (28)

1. Araya, M., Olivares, M., Pizarro, F., Llanos, A., Figueroa, G. & Uauy, R. (2004) Community-based randomized double-blind study of gastrointestinal effects and copper exposure in drinking water. Environ. Health. Perspect. 112: 1068-1073.
2. Araya, M., McGoldrick, M. C., Klevay, L., Strain, J. J., Robson, P., Neilsen, F., Olivares, M., Pizarro, F., Johnson, L., et al. (2001) Determination of an acute no-observed-adverse-effect-level (NOAEL) for copper in water. Regul. Toxicol. Pharmacol. 34: 137-145.
3. Olivares, M., Araya, M., Pizarro, F. & Uauy, R. (2001) Nausea threshold in apparently healthy individuals who drink fluids containing graded concentrations of copper. Regul. Toxicol. Pharmacol. 33: 271-275.
4. Araya, M., Olivares, M., Pizarro, F., Gonzalez, M., Speisky, H. & Uauy, R. (2003) Gastrointestinal symptoms and blood indicators of copper load in apparently healthy adults undergoing controlled copper exposure. Am. J. Clin. Nutr. 77: 646-650.
5. Kehoe, C. A., Turley, E., Bonham, M. P., O'Connor, M., McKeown, A., Faughan, M. S., Coulter, J. S., Gilmore, W. S., Howard, A. N. & Strain, J. J. (2000) Response of putative indices of copper status to copper supplementation in human subjects. Br. J. Nutr. 84: 151-156.
6. Johnson, M. A., Smith, M. M. & Edmonds, J. T. (1998) Copper, iron, zinc and manganese in dietary supplements, infant formulas and ready-to-eat breakfast cereals. Am. J. Clin. Nutr. 67: 1035S-1040S.
7. O'Donohue, J. W., Reid, M. A., Varghese, A., Portmann, B. & Williams, R. (1993) Micronodular cirrhosis and acute liver failure due to chronic copper self-intoxication. Eur. J. Gastroenterol. Hepatol. 5: 561-562.
8. Institute of Medicine, Food and Nutrition Board (2001) Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iran, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press, Washington, DC.
9. Cashman, K. D., Baker, A., Ginty, F., Flyn, A., Strain, J. J., Bonham, M. P., O'Connor J. M. & Bagel, S. (2001) No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status. Eur. J. Clin. Nutr. 55: 525-531.
10. Jones, A. A., DiSilvestro, R. A., Coleman, M. & Wagner, T. L. (1997) Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk. Metabolism 46: 1380-1383.
11. Lowe, N. M., Lowe, N. M., Fraser, W. D. & Jackson, M. J. (2002) Is there a potential therapeutic value of copper and zinc for osteoporasis? Proc. Nutr. Soc. 61: 181-185.
12. Olivares, M., Pizarro, F., de Pablo, S., Araya, M. & Uauy, R. (2004) Iron, zinc and copper: contents in common Chilean foods and daily intakes in Santiago City, Chile. Nutrition 20: 205-212.
13. Aaseth, J., Benov, L. & Ribarov, S. (1990) Mercaptodextran-a new copper chelator and scavenger of oxygen radicals. Zhongguo Yaoli Xuebao 11: 363-367.
14. Hoogenraad, T. U. & Van Hattum, J. (1985) Unithiol in Wilson's disease. Br. Med. J. 290: 1213.
15. Ren, M. S., Hu, W. B., Zhang, Z., Ju, S. W., Fan, Y. X., Wang, G. Q. & Yang, R. M. (1998) Copper-chelating therapeutic effect in Wilson disease with different clinical phenotypes and polymorphisms of ATP7B gene. World. J. Gastroenterol. 4: 340-342.
16. St. Louis, P. J. (1991) Biochemical studies: liver and intestine. In: Pediatric Gastroenterology Disease (Walker, W. A., Durie, P. R., Hamilton, J. R., Walker-Smith, J. A. & Watkins, J. B., eds.), pp. 1363-1374. BC Decker, Toronto, Canada.
17. FAO/WHO/IAEA (1996) Trace Elements in Human Nutrition and Health, WHO, Geneva, Switzerland.
18. Mukai, M., Ozasa, K., Hayashi, K. & Kawai, K. (2002) Various S-GOT/ S-GPT ratios in nonviral liver disorders and related physical conditions and life-style. Dig. Dis. Sci. 47: 549-555.
19. Alexander, J. & Aaseth, J. (1980) Biliary excretion of copper and zinc in the rat as influenced by diethylaleate, selenite and diethyl dithioncarbamate. Biochem. Pharmacol. 29: 2129-2133.
20. Dijkstra, M., Kuipers, F., van der Berg, P., Haninga, R. & Vonk, R. J. (1997) Differences in hepatic processing of dietary and intravenously administered copper in rats. Hepatology 26: 962-966.
21. Burgunder, J. M. & Lauterburg, B. H. (1987) Decreased production of glutathione in patients with cirrhosis. Eur. J. Clin. Investig. 17: 408-414.
22. Summer, K. H. & Eisenburg, J. (1985) Low content of hepatic reduced glutathione in patients with Wilson disease. Biochem. Med. 34: 107-111.
23. Buhl, R., Holroyd, K. J., Mastrangeli, A. & Cantin, A. M. (1989) Systemic glutathione deficiency in symptom-free HIV seropositive individuals. Lancet 2: 1294-1298.
24. Takeda, T., Yukioka, T. & Shimazaki, S. (2000) Cupric sulfate intoxication with rhabdomyolysis, treated with chelating agents and blood purification. Intern. Med. 39: 253-255.
25. Umweltmedizin http://www.medizin-links.de/ziegler/fachinformationen/ umweltmedizin.htm (accessed January 12, 2005).
26. Blanusa, M., Prester, L., Radic, S. & Kargacin, B. (1994) Inorganic mercury exposure, mercury-copper interaction, and DMPS treatment in rats. Environ. Health. Perspect. 102 (suppl.): 305-307.
27. Schuurs, A., Exterkate, R. & ten Cate, B. (2000) Biological mercury measurements before and after administration of a chelator (DMPS) and subjective symptoms allegedly due to amalgam. Eur. J. Oral Sci. 108: 511-522.
28. Torres-Alanis, O., Garza-Ocanas, L., Bernal, M. A. & Pineyro-Lopez, A. (2000) Urinary excretion of trace elements in humans after sodium 2,3-dimercaptopropane-1-sulfonate challenge test. J. Toxicol. Clin. Toxicol. 38: 697-700.